214 related articles for article (PubMed ID: 27452811)
1. Idarucizumab for dabigatran reversal in patients with atrial fibrillation undergoing emergency surgery for acute aortic syndrome.
Mazur P; Darocha T; Filip G; Grudzień G; Drwiła R; Kapelak B
Pol Arch Med Wewn; 2016 Jul; 126(7-8):579-81. PubMed ID: 27452811
[No Abstract] [Full Text] [Related]
2. Reversal of dabigatran-associated bleeding using idarucizumab: review of the current evidence.
Giustozzi M; Verso M; Agnelli G; Becattini C
J Thromb Thrombolysis; 2017 Nov; 44(4):527-535. PubMed ID: 28913672
[TBL] [Abstract][Full Text] [Related]
3. Reversal of Dabigatran with Idarucizumab.
Sodha NR; Sellke FW
Expert Rev Cardiovasc Ther; 2016 Aug; 14(8):889-93. PubMed ID: 27362456
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment with idarucizumab for diffuse alveolar hemorrhage induced by dabigatran etexilate: a case report.
Shiroshita A; Nakashima K; Tanaka Y; Tateishi A; Nemoto M; Aoshima M
J Thromb Thrombolysis; 2018 Aug; 46(2):271-273. PubMed ID: 29740732
[TBL] [Abstract][Full Text] [Related]
5. Idarucizumab for the treatment of hemorrhage and dabigatran reversal in patients requiring urgent surgery or procedures.
Vornicu O; Larock AS; Dincq AS; Douxfils J; Dogné JM; Mullier F; Lessire S
Expert Opin Biol Ther; 2017 Oct; 17(10):1275-1296. PubMed ID: 28728489
[TBL] [Abstract][Full Text] [Related]
6. [First NOAk specific antidote as additional safety factor in therapy].
MMW Fortschr Med; 2016 Feb; 158(2):66-7. PubMed ID: 27017635
[No Abstract] [Full Text] [Related]
7. Safe Burr Hole Surgery for Chronic Subdural Hematoma Using Dabigatran with Idarucizumab.
Arai N; Mine Y; Kagami H; Maruyama M; Daikoh A; Inaba M
World Neurosurg; 2018 Jan; 109():432-435. PubMed ID: 29054780
[TBL] [Abstract][Full Text] [Related]
8. Emergency LP in a patient receiving dabigatran after antagonization with idarucizumab.
Braemswig TB; Eschenfelder CC; Nolte CH
Am J Emerg Med; 2017 Apr; 35(4):662.e3-662.e4. PubMed ID: 27836320
[TBL] [Abstract][Full Text] [Related]
9. Real-life experience with the specific reversal agent idarucizumab for the management of emergency situations in dabigatran-treated patients: a series of 11 cases.
Vosko MR; Bocksrucker C; Drwiła R; Dulíček P; Hauer T; Mutzenbach J; Schlimp CJ; Špinler D; Wolf T; Zugwitz D
J Thromb Thrombolysis; 2017 Apr; 43(3):306-317. PubMed ID: 28210988
[TBL] [Abstract][Full Text] [Related]
10. Successful intravenous thrombolysis for ischemic stroke after reversal of dabigatran anticoagulation with idarucizumab: a case report.
Agosti S; Casalino L; Rocci E; Zaccone G; Rota E
J Med Case Rep; 2017 Aug; 11(1):224. PubMed ID: 28806993
[TBL] [Abstract][Full Text] [Related]
11. Reversal of dabigatran by idarucizumab: when and how?
Vanassche T; Greinacher A; Verhamme P
Expert Rev Hematol; 2016 Jun; 9(6):519-28. PubMed ID: 27166653
[TBL] [Abstract][Full Text] [Related]
12. Idarucizumab for Dabigatran Reversal in the Management of Patients With Gastrointestinal Bleeding.
Van der Wall SJ; Lopes RD; Aisenberg J; Reilly P; van Ryn J; Glund S; Elsaesser A; Klok FA; Pollack CV; Huisman MV
Circulation; 2019 Feb; 139(6):748-756. PubMed ID: 30586692
[TBL] [Abstract][Full Text] [Related]
13. [The first use of iv. idarucizumab for dabigatran reversal in Hungary].
Driesz L; Barabás É; Bodócs I; Szántó Z; Herr G; Bencsik G; Pál L; Borbola J
Orv Hetil; 2017 Mar; 158(10):387-392. PubMed ID: 28270004
[TBL] [Abstract][Full Text] [Related]
14. Healthcare resource utilization in patients receiving idarucizumab for reversal of dabigatran anticoagulation due to major bleeding, urgent surgery, or procedural interventions: interim results from the RE-VERSE AD™ study.
Pollack CV; Bernstein R; Dubiel R; Reilly P; Gruenenfelder F; Huisman MV; Kam CW; Kleine E; Levy JH; Sellke FW; Steiner T; Ustyugova A; Weitz JI
J Med Econ; 2017 May; 20(5):435-442. PubMed ID: 27981865
[TBL] [Abstract][Full Text] [Related]
15. Spotlight on idarucizumab and its potential for the reversal of anticoagulant effects of dabigatran.
Sié P
Drug Des Devel Ther; 2016; 10():1683-9. PubMed ID: 27274201
[TBL] [Abstract][Full Text] [Related]
16. Emergency abdominal surgery in a patient anticoagulated with dabigatran.
DeMuro JP
Ulus Travma Acil Cerrahi Derg; 2013 Sep; 19(5):469-71. PubMed ID: 24214790
[TBL] [Abstract][Full Text] [Related]
17. Severe obscure gastrointestinal bleeding successfully treated with idarucizumab.
Rodríguez de Santiago E; Sierra Morales M; Martínez González J
Rev Esp Enferm Dig; 2018 Apr; 110(4):264-265. PubMed ID: 29368938
[TBL] [Abstract][Full Text] [Related]
18. Idarucizumab for Reversal of Dabigatran Prior to Acute Surgery: A Schematic Approach Based on a Case Report.
Rosenberg L; Gerstrøm G; Nybo M
Basic Clin Pharmacol Toxicol; 2017 Apr; 120(4):407-410. PubMed ID: 27797449
[TBL] [Abstract][Full Text] [Related]
19. Real-World Experience with Idarucizumab to Reverse Anticoagulant Effect in Dabigatran-Treated Patients: Report of 11 Cases from Taiwan.
Tsai LK; Lin HJ; Chua SK; Liao PC; Yang YP; Chou PC; Lee CW; Lin MJ; Chen HM; Yeh JT; Li YH
J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):e27-e33. PubMed ID: 29122465
[TBL] [Abstract][Full Text] [Related]
20. [First NOAK antidote soon to be approved].
Holzgreve H
MMW Fortschr Med; 2015 Aug; 157(14):34. PubMed ID: 26289876
[No Abstract] [Full Text] [Related]
[Next] [New Search]
